Diclonixin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C12H8Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 357591W853, chemically known as 2-(2,3-dichloroanilino)-nicotinic acid. but generally known as diclonixin, which bears US NIH Compound Identifier 208833. European Medicines Agency schedules Diclonixin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07097MIG. The term DICLONIXIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). DICLONIXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diclonixin under HS 29333999 and SITC 51574. As of Q4 2014, DICLONIXIN remains the US FDA Preferred Term for this commodity. Diclonixin bears US NLM identifiers UMLS ID C2699632 and NCI Concept Code C77356. SMILES: CLC1C(NC2NCCCC2C(=O)O)CCCC1CL.